Kering Sa Earnings Calls
| Release date | Jul 27, 2026 |
| EPS estimate | 3.54€ |
| EPS actual | - |
| Revenue estimate | 3.65B |
| Revenue actual | - |
| Expected change | +/- 3.64% |
| Release date | Feb 10, 2026 |
| EPS estimate | 2.42€ |
| EPS actual | 1.23€ |
| EPS Surprise | -49.17% |
| Revenue estimate | 7.344B |
| Revenue actual | 7.088B |
| Revenue Surprise | -3.49% |
| Release date | Jul 29, 2025 |
| EPS estimate | 3.49€ |
| EPS actual | 3.67€ |
| EPS Surprise | 5.16% |
| Revenue estimate | 3.974B |
| Revenue actual | 7.587B |
| Revenue Surprise | 90.94% |
| Release date | Jul 22, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Kering Sa
Below you can see how PPX.DE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 22, 2025 |
| Price on release | 202.60€ |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 16, 2025 | 192.42€ |
| Jul 17, 2025 | 192.96€ |
| Jul 18, 2025 | 197.06€ |
| Jul 21, 2025 | 197.34€ |
| Jul 22, 2025 | 202.60€ |
| Jul 23, 2025 | 212.85€ |
| Jul 24, 2025 | 212.15€ |
| Jul 25, 2025 | 221.55€ |
| Jul 28, 2025 | 215.70€ |
| 4 days before | 5.29% |
| 4 days after | 6.47% |
| On release day | 5.06% |
| Change in period | 12.10% |
| Release date | Jul 29, 2025 |
| Price on release | 213.05€ |
| EPS estimate | 3.49€ |
| EPS actual | 3.67€ |
| EPS surprise | 5.16% |
| Date | Price |
|---|---|
| Jul 23, 2025 | 212.85€ |
| Jul 24, 2025 | 212.15€ |
| Jul 25, 2025 | 221.55€ |
| Jul 28, 2025 | 215.70€ |
| Jul 29, 2025 | 213.05€ |
| Jul 30, 2025 | 215.65€ |
| Jul 31, 2025 | 216.40€ |
| Aug 01, 2025 | 215.85€ |
| Aug 04, 2025 | 215.10€ |
| 4 days before | 0.0940% |
| 4 days after | 0.96% |
| On release day | 1.22% |
| Change in period | 1.06% |
| Release date | Feb 10, 2026 |
| Price on release | 287.40€ |
| EPS estimate | 2.42€ |
| EPS actual | 1.23€ |
| EPS surprise | -49.17% |
| Date | Price |
|---|---|
| Feb 04, 2026 | 264.15€ |
| Feb 05, 2026 | 259.20€ |
| Feb 06, 2026 | 258.35€ |
| Feb 09, 2026 | 259.10€ |
| Feb 10, 2026 | 287.40€ |
| Feb 11, 2026 | 279.40€ |
| Feb 12, 2026 | 281.30€ |
| Feb 13, 2026 | 284.40€ |
| Feb 16, 2026 | 270.30€ |
| 4 days before | 8.80% |
| 4 days after | -5.95% |
| On release day | -2.78% |
| Change in period | 2.33% |
| Release date | Jul 27, 2026 |
| Price on release | - |
| EPS estimate | 3.54€ |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 29, 2026 | 265.55€ |
| Jun 30, 2026 | 247.50€ |
| Jul 01, 2026 | 246.05€ |
| Jul 02, 2026 | 252.70€ |
| Jul 03, 2026 | 248.40€ |
Kering Sa Earnings Call Transcript Summary of Q4 2025
Kering reported 2025 as a low point but a deliberate inflection: full-year revenue (ex-Kering Beaute) was EUR 14.7bn, down 10% on a comparable basis, with sequential improvement through the year and Q4 at -3%. Recurring EBIT was EUR 1.6bn (11.1% margin), down 33% year‑on‑year; free cash flow was EUR 4.4bn including real estate transactions (EUR 2.3bn excluding). Net financial debt fell by EUR 2.5bn to EUR 8.0bn year‑end, and the planned sale/partnership with L'Oreal (closing H1 2026) will bring ~EUR 4bn cash, further strengthening the balance sheet. Management implemented significant discipline: ~EUR 925m of cost savings in 2025, 75 net store closures in 2025 with at least 100 net closures planned for 2026, and an 8% inventory reduction. Strategic moves: partnership with L'Oreal to accelerate beauty and expand into wellness/longevity, and progressive acquisition of Raselli to scale jewelry capabilities. Brand highlights: Gucci remains the largest house and is beginning to show early signs of product-led recovery but still is the primary turnaround focus; Saint Laurent and Bottega Veneta are stronger and more growth-ready; Balenciaga and Alexander McQueen require further work (McQueen restructuring underway). Outlook and capital allocation: management expects 2026 to be a constructive year — a return to growth and margin improvement, executed gradually quarter-to-quarter. Leverage is expected to fall materially post-closing of the Kering Beaute transaction (Armelle indicated a pro-forma leverage range of ~1.0–1.5x). Board proposed a EUR 3.00 ordinary dividend and an exceptional EUR 1.00 dividend tied to the Beaute disposal. Key near-term catalysts: Capital Markets Day on April 16 (strategy/details by house), Q1 revenue release (April 14), and closing of the L'Oreal deal in H1 2026. Main investor considerations/risks: recovery is early and fragile, Gucci's rebound is critical to group momentum, continued store rationalization will dent short-term sales while improving long-term density, and macro/tourism (esp. APAC/China) and currency effects remain meaningful.
Sign In
Buy PPX